The CUREator+ Dementia and Cognitive Decline incubator program is a partnership between
Brandon BioCatalyst, ANDHealth and
Dementia Australia.
Companies that are pioneering innovative health technologies to enhance the lives of individuals affected by dementia and cognitive decline up can apply to receive up to $5 million per project in non-dilutive project funding.
Funded by the Federal Government’s $20 billion Medical Research Future Fund (MRFF), this $50 million program aims to support the development of novel approaches, spanning therapeutics, diagnostics, assistive and medical devices and digital health technologies, that will prolong or improve the lives of the estimated 433,300 Australians currently living with Dementia and the 1.7 million caregivers who support them.
The program delivers funding in tranches tied to mutually agreed-upon milestones and will leverage Australia’s globally recognised life sciences research and health technology strengths to enhance the commercialisation and translation of innovations that improve health and wellbeing.
By aligning funding incentives and progress, CUREator+ aims to cultivate a thriving local ecosystem of innovation and entrepreneurship dedicated to tackling the escalating global issue of Dementia and Cognitive Decline.
.svg)
